Previous Article | Next Article 
Infection and Immunity, September 1999, p. 4843-4846, Vol. 67, No. 9
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Human
-Defensin-1 mRNA Is Transcribed in
Tympanic Membrane and Adjacent Auditory Canal Epithelium
Roald
Bøe,1,*
Juha
Silvola,2
Jinghui
Yang,1
Ugo
Moens,3
Paul B.
McCray Jr.,4
Lars-Eric
Stenfors,2 and
Rolf
Seljfelid1
Departments of Experimental
Pathology,1
Otolaryngology,2 and Molecular
Genetics,3 University of Tromsø, Tromsø,
Norway, and Department of Pediatric Allergy and Pulmonary
Division, University of Iowa Hospital and Clinics, Iowa City,
Iowa4
Received 15 March 1999/Returned for modification 29 April
1999/Accepted 10 June 1999
 |
ABSTRACT |
The external auditory canal is less susceptible to infections than
the sensitive middle-ear cavity. Since recent research has provided
insight to the production of potent antimicrobial peptides from various
surface epithelia, we wanted to investigate whether protection of the
external auditory canal in part could be explained by the production of
human
-defensin-1 (HBD-1). This particular peptide is known to be
constitutively expressed in various surface epithelia, such as airway,
skin, and urogenital tissues. By reverse transcriptase PCR we
demonstrate HBD-1 mRNA in the pars tensa and pars flaccida of the
tympanic membrane and in the meatal skin. In situ hybridization studies
localized the HBD-1 mRNA to the epidermal layer of these tissues. The
HBD-1 transcripts were also evident in the sebaceous glands
and in hair follicles of the meatal skin. In contrast, HBD-1 mRNA
was not detected in the tympanal epithelium of the eardrum. The
widespread presence of mRNA encoding for this broad-spectrum
antimicrobial peptide in the meatal skin and tympanic membrane suggests
that HBD-1 participates in the innate antimicrobial defense of the external auditory canal and middle-ear cavity.
 |
INTRODUCTION |
The external auditory canal (EAC) is
a special anatomic region, forming a "cul-de-sac" with the thin
tympanic membrane (TM) separating the EAC from the sterile environment
of the middle-ear cavity. It is well known that organisms potentially
pathogenic to the middle ear can be found in the EAC (4, 5,
25). These circumstances make it obvious that the intact TM
provides an effective physical barrier, preventing the penetration and entrance of pathogenic microorganisms from the EAC into the sensitive middle-ear cavity. The external surface of the intact TM is covered with a stratified and keratinized surface epithelium, which
participates in preventing EAC microorganisms from reaching the middle
ear cavity. In addition, cerumen, which is a combination of ceruminous and sebaceous secretions, exerts antimicrobial properties that tend to
eliminate pathogenic organisms (28).
During recent years, endogen antimicrobial peptides, active against
gram-positive and gram-negative bacteria, have attracted much interest
(2, 3, 8, 13, 20). Defensins, a subgroup of these
substances, are small peptides of 29 to 47 amino acids which have been
classified into the two families,
-defensins and
-defensins.
Whereas some
-defensins are expressed in the Paneth cells of the
gastrointestinal tract, others have been demonstrated in neutrophil
granulocytes where these peptides constitute 5 to 7% of the total
protein content (9). These polypeptides function in both
phagocytic and extracellular killing of microbes and are therefore
important for host defense (9). Human
-defensin-1 (HBD-1)
was recently isolated from plasma (1) and was shown to be constitutively expressed in salivary glands (30), in
gingival cells (12), in urogenital tissues (29,
30), in the pancreas (23, 30), in the respiratory
epithelium of the lower airways (18), and in keratinocytes
of the skin (7).
The purpose of the present study was to investigate whether the
effective impediment against infections in the inner part of the EAC
could in part be explained by evidence for HBD-1 peptide production.
The pars tensa and pars flaccida from eardrums, and meatal skin tissue
were investigated by using reverse transcriptase PCR (RT-PCR) and in
situ hybridization techniques. We found that the surface epithelium of
the eardrum and meatal skin contained mRNA for the antimicrobial
peptide HBD-1. Considering both this widespread presence of the HBD-1
mRNA in the region and its known broad-spectrum antibiotic activity, we
suggest that HBD-1 contributes significantly to the antimicrobial
protection of the EAC, the TM, and the middle-ear cavity.
 |
MATERIALS AND METHODS |
Tissue sampling.
TMs with adjacent skin were dissected at
autopsy from 10 ears within 36 h postmortem with an endoscope. No
signs of ear disease were observed at inspection prior to excision.
After removal, tissues from the pars tensa and the pars flaccida of the
eardrum and meatal skin were separated. In addition, small meatal skin pieces were excised during otosclerosis surgery of five patients. Special care was made to sample skin fragments uninvolved by the disease for which the patients were operated. The specimens were either
prepared for RT-PCR or in situ hybridization studies. The study was
approved by the Medical Ethics Committee of the University of Tromsø,
Tromsø, Norway.
RT-PCR.
Total RNA from the tissue fragments (1 mm3) was isolated by the single-step guanidium
thiocyanate-phenol-chloroform extraction method (6). The RT
reaction was performed mainly as recently described (17). In
brief, 5 µl of RNA (1 µg) was added to 55 µl of an RT mixture
containing 60 U of RNasin (Promega), 0.63 mM concentrations of each
deoxynucleotide from a deoxynucleoside triphosphate mix (Pharmacia
Biotech), 0.3 ng of pd(N)6 Random Hexamer primers
(Pharmacia Biotech), 600 U of Molony leukemia virus RT (Gibco/Life
Technologies) in 1× RT buffer (Gibco), and incubated for 1 h at
37°C. For negative control of the RT reaction, 5 µl of
DEPC-H2O was added to the RT mixture. The reaction products were heated (100°C) for 10 min, chilled on ice, and spun briefly before 240 µl of DEPC-H2O was added to each sample. The
primers used for the PCR were the forward primer A1
(5'-TTGTCTGAGATGGCCTCAGGTGGTAAC-3' [30])
and the reverse primer R3 (5'-TTTCACTTCTGCGTCATTTCTTCTGG-3'). The A1 primer corresponds to the nucleotides 753 to 771 in exon 1 and includes sequence 7734 to 7741 in exon 2 (numbering according to
Liu et al. [16]). The reverse primer R3 is
complementary to nucleotides 7890 to 7916 in exon 2. The expected size
of the PCR product generated from these primers was 200 bp. The primers 5'-CCCGAGGCTTCCTCTTTGGC-3' and
5'-CCTCGCTTAAGGGCAGGGAG-3' for the housekeeping gene
adenosylphosphoribosyltransferase (APRT) were run simultaneously (the
expected size of this PCR product was 300 bp). The primers correspond
to the sequence 1940 to 1959 in exon 3 and 2725 to 2744 in exon 5 of
the APRT gene, respectively (GenBank access number Y00486). The primers
were purchased from Eurogenetec. The samples were denatured at 94°C
for 5 min and amplified by 35 cycles at 94°C for 1 min, at 60°C for
1 min, and at 72°C for 1 min. For a final elongation step, the
samples were incubated for 5 min at 72°C. The PCR products were
analyzed by gel electrophoresis.
In situ hybridization.
The cDNA used for the preparation of
the sense and antisense HBD-1 probes has been described recently
(29). RNA-probes for in situ hybridization were prepared by
using the DIG RNA Labeling Kit (Boehringer Mannheim). The dissected
specimens were fixed by immersion overnight in 4% paraformaldehyde (pH
7.4) at 4°C. Paraffin sections were mounted on glass slides which had
been pretreated with 1% 3-aminopropyl-trietoxysilane (ICN). Some
sections were stained with hematoxylin and eosin for histological
examination. Parallel sections were deparaffinized and hydrated prior
to an incubation for 15 min in phosphate-buffered saline (PBS)-0.3% Triton X-100. Digestion was performed for 45 min with 25 µg of proteinase K (Boehringer Mannheim) per ml in 0.1 M Tris-HCl and 0.05 M
EDTA (pH 8.0) at 37°C. The proteinase K activity was stopped by
incubating the slides in PBS-4% paraformaldehyde for 5 min. The
slides were washed twice for 3 min in sterile water, and the sections
were acetylated by soaking them into 0.1 M triethanolamine-HCl (Sigma),
to which 0.375 ml of acetic anhydride (Sigma) was added twice (with 5 min of incubation after each addition). After dehydration in sequential
ethanol baths and drying (20°C, 60 min), hybridization solution (100 µl) containing 0.3 M NaCl, 20 mM Tris-HCl (pH 7.2), 5 mM EDTA,
Denhardt solution (Sigma), 50% deionized formamide, 10% dextran
sulfate, 0.25 mg of yeast tRNA per ml, and 250 ng of DIG-labeled RNA
probe per ml was applied onto each section. The hybridization solution
was overlaid with parafilm, and all samples were incubated overnight at
42°C in a moisture chamber. The sections were incubated in 2× SSC
(1× SSC is 0.15 M NaCl plus 0.015 M sodium citrate) at 50°C for 45 min and in 0.2× SSC at 50°C for 30 min and then briefly immersed in
sterile water. The sections were then incubated twice for 10 min in
Tris-HCl-NaCl buffer (pH 7.5) and for 20 min in blocking buffer
(Tris-HCl-NaCl buffer with 1% bovine serum albumin and 2% sheep
serum). The sections were subsequently incubated for 2 h with the
anti-DIG-AP Fab fragment antibody (Boehringer Mannheim) diluted to
1:300 in a 1:1 mixture of the Tris-HCl-NaCl buffer (pH 7.5) and the
blocking buffer. Cells with hybridized probe were visualized by
incubation for 12 h (4°C) with nitroblue tetrazolium,
5-bromo-4-chloro-3-indolyl phosphate, and levamisole (Sigma). The
specimens were examined in a Zeiss Axioplan microscope (Oberkochen, Germany).
 |
RESULTS |
RT-PCR studies.
The RT-PCR examination showed that biopsied
skin from the EAC and autopsied tissue pieces of the pars tensa and the
pars flaccida of the eardrum (Fig. 1)
contained mRNA encoding for HBD-1 (Fig. 2). The PCR products extracted from all
of the anatomical sites had the size (200 bp) which was expected from
the selected primers. For a control, the linearized pCR3.1 vector
containing the full-length HBD-1 cDNA was amplified with the same
primers, which also generated a PCR product of 200 bp. Sequencing of
the RT-PCR products confirmed 100% sequence homology to the HBD-1 (not
shown). The primers used for the housekeeping gene (APRT, see Materials
and Methods for specifications), produced a PCR product (300 bp) from
each of the tissue samples. The APRT primers gave no signal when tested with the linearized HBD-1 cDNA vector.

View larger version (52K):
[in this window]
[in a new window]
|
FIG. 1.
Illustration of the TM separating the middle-ear cavity
(MEC) from the EAC. The pars tensa (PT) of the TM is shown, and the
arrow demonstrates the location of the pars flaccida.
|
|

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 2.
RT-PCR products of mRNA from biopsied (A) and autopsied
(B) tissues, as demonstrated by gel electrophoresis. The 200-bp
fragments represent the presence of mRNA for HBD-1, and the 300-bp
fragments represent the control APRT mRNA product. (A) Lanes: 1, negative control (running the RT procedure with sterile water); 2, RT-PCR of mRNA collected from an EAC skin sample; 3, control tissue
sample from skin; 4, PCR product obtained by amplification of the cDNA
for HBD-1 inserted in the pCR3.1 plasmid. (B) Lanes: 1, RT-PCR products
from an autopsied tissue fragment of EAC skin; 2, pars tensa of the TM;
3, pars flaccida of the TM; 4, negative control; 5, amplification
product of the HBD-1 cDNA.
|
|
Light microscopy studies of the eardrum and adjacent skin.
Light microscopy studies showed that the skin of the EAC (Fig. 3A to
C) possessed a well-defined epidermis and
dermis. Sebaceous and ceruminous glands originating from the epidermal
layer were observed in the dermis. The TM (Fig. 3D to F) had an outer
meatal side consisting of keratinizing, stratified, squamous epithelium that was three to seven cells thick. Underlying the epithelium, the
thin layer of connective tissue is arranged with two layers of loose
connective tissue, covering each side of a middle layer of collagen
fibers as described previously (14, 15, 26). In the pars
flaccida (Fig. 3G to I), the keratin layer of the meatal epithelium was
more distinct than in the pars tensa (Fig. 3D). The single-layered
tympanal epithelium did not differ from that lining the pars tensa. The
connective tissue portion of the pars flaccida (Fig. 3G) was somewhat
thicker than that of the pars tensa (Fig. 3D). As seen from Fig. 3D and
G, the autopsied material showed minor postmortem changes.

View larger version (95K):
[in this window]
[in a new window]
|
FIG. 3.
In situ hybridization studies showing the localization
of the HBD-1 mRNA in the epidermal layer of the EAC skin, pars tensa,
and pars flaccida. Parallel micrographs from the meatal skin (A to C),
from the pars tensa (D to F), and from the pars flaccida (G to I) are
shown. The sections presented in panels A, D, and G were stained with
hematoxylin and eosin; panels B, E, and H show parallel sections
hybridized with DIG-labeled antisense RNA probe for HBD-1, and panels
C, F, and I were from control sections hybridized with DIG-labeled
sense transcript for potential nonspecific labeling. MEC, middle-ear
cavity. Bars, 80 µm.
|
|
In situ hybridization studies.
The keratinocytes of the meatal
skin epidermis, as well as keratinocytes of pars tensa and pars
flaccida, stained positive for HBD-1 mRNA (Fig. 3B, E, and H). In
contrast, the flat monolayered tympanal epithelium facing the MEC and
the connective tissue of the skin (dermis) and the TM showed no
staining (Fig. 3B, E, and H). In the meatal skin epidermis, it seemed
to be mainly the keratinocytes of the middle layers (stratum
granulosum) that were stained (Fig. 3B). A striking observation was
also the pronounced staining of cells in the sebaceous glands and hair
follicles (Fig. 3B). There was no specific localization with the
DIG-labeled sense transcript for HBD-1 (Fig. 3C, F, and I), confirming
the specificity of the antisense HBD-1 probe. The same patterns of
staining were observed in biopsy and in autopsy material.
 |
DISCUSSION |
Clinical observations suggest that the EAC, which is frequently
exposed to microbial pathogens, actually is less disposed to infections
than the middle-ear cavity. Being unique in that it separates the two
gas-filled environments (Fig. 1), the TM provides a physical barrier
which prevents EAC pathogens from reaching the middle ear. To fulfill
its prime function as a vibrating membrane, the eardrum is so thin that
structures such as the ossicles of the middle ear and the promontory
with the round window niche can be discerned behind it. The morphology
of the human TM with adjacent skin is well described (14, 15,
26), and our study confirmed earlier findings.
Recent research has demonstrated that various epithelial surfaces
express a variety of effective antibiotic peptides. We therefore presumed that these peptides also could be present in the eardrum surface epithelium and the adjacent EAC skin. Antimicrobial peptides produced by the TM could prevent bacterial microorganisms, normally colonizing the EAC, from reaching the vulnerable middle-ear cavity. Under normal conditions, Staphylococcus epidermidis,
Corynebacterium spp., Micrococcus spp., and
alpha-hemolytic and nonhemolytic streptococci, but also small numbers
of Staphylococcus aureus and pseudomonas aeruginosa, are normal commensals of the EAC (4, 21,
25). The most common bacteria causing acute otitis media,
Streptococcus pneumoniae, Haemophilus influenzae,
and Moraxella catarrhalis, are not normally found in the EAC
when the eardrum is intact (11). In contrast, S. aureus and P. aeruginosa are well-known pathogens in
chronically inflamed, draining ears.
We found that keratinocytes of the EAC epidermis and eardrums were the
site of mRNA transcription for the HBD-1 peptide. HBD-1 has previously
been shown constitutively expressed in keratinocytes of the skin
(7), and our findings of mRNA for HBD-1 in the EAC
keratinocytes are consistent with these results. On the other hand, we
did not find evidence of HBD-1 production in the tympanal epithelium.
The defensins, when tested in vitro, exhibit potent antimicrobial
effects against gram-positive and gram-negative bacteria
(13). Specifically, HBD-1 has microbicidal effects against
the gram-negative P. aeruginosa (24). As reviewed
by Lehrer et al. (13), defensins are also able to kill some
fungi, among them Candida spp. Important questions regarding
the mode of action of
-defensins on microorganisms in the EAC still
exist. Is the peptide transported extracellularly, or is it only acting on bacteria that penetrate into the epithelial cells? It seems reasonable to believe that HBD-1 acts mainly extracellularly, as it may
in bronchoalveolar lavage fluid (24) and in the urogenital tract (29). Another important question is whether additional amounts of other peptide antibiotics, e.g., HBD-2 (10, 24), can be induced in keratinocytes of the EAC. The fact that HBD-1 is
transcribed in the cells of the sebaceous glands (Fig. 3H) suggests
that the antimicrobial peptide is expressed and secreted with the
cerumen of the EAC. Cerumen from sebaceous and ceruminous glands
contains fatty acids and lysozyme and has previously been shown to
exert bacteriostatic or bactericidal effects (28). The
function of cerumen is controversial since it also can serve as an
excellent substrate for Pityrosporum ovale (27),
a lipophilic yeast that is the etiologic agent of dandruff
(19) and folliculitis (22). Further studies are
needed to reveal whether or not HBD-1 is able to kill P. ovale. On the basis of our findings we speculate that HBD-1,
produced by the secretory glands and keratinocytes of the EAC,
contributes to the bactericidal activity of cerumen in addition to
lysozyme (28). These findings, taken together, suggest that
HBD-1 contributes to the antimicrobial defense of the TM and the EAC.
 |
ACKNOWLEDGMENTS |
We are grateful to Wenche Helen Bakkelund and Anja Inkeri
Vepsä for excellent technical assistance. We are also indebted to
Marijke Van Ghelue for the DNA sequencing.
The work was supported by grants from the Norwegian Research Council
(Norges Forskningsråd).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Experimental Pathology, Institute of Medical Biology, University of
Tromsø, Breivika, N-9037 Tromsø, Norway. Phone: (47) 7764-6391. Fax:
(47) 7764-5400. E-mail: roaldb{at}fagmed.uit.no.
Editor:
D. L. Burns
 |
REFERENCES |
| 1.
|
Bensch, K. W.,
M. Raida,
H. J. Magert,
P. Schulz Knappe, and W. G. Forssmann.
1995.
hBD-1: a novel beta-defensin from human plasma.
FEBS Lett.
368:331-335[Medline].
|
| 2.
|
Boman, H. G.
1998.
Gene-encoded peptide antibiotics and the concept of innate immunity: an updated review.
Scand. J. Immunol.
48:15-25[Medline].
|
| 3.
|
Boman, H. G.,
I. Nilsson, and B. Rasmuson.
1972.
Inducible antibacterial defence system in Drosophila.
Nature
237:232-235[Medline].
|
| 4.
|
Brook, I.
1981.
Microbial studies of the bacterial flora of the external auditory canal in children.
Acta Otolaryngol.
91:285-287[Medline].
|
| 5.
|
Brooks, G. F.,
J. S. Butel,
L. N. Ornson,
E. Jawetz,
J. L. Melnick, and E. A. Adelberg.
1991.
Jawetz, Melnick, and Adelberg's medical microbiology, 19th ed.
Prentice-Hall Inc., London, United Kingdom.
|
| 6.
|
Chomczynski, P., and N. Sacchi.
1987.
Single step method of RNA isolation by guanidium thiocyanate-phenol-chloroform extraction.
Anal. Biochem.
162:156-159[Medline].
|
| 7.
|
Fulton, C.,
G. M. Anderson,
M. Zasloff,
R. Bull, and A. G. Quinn.
1997.
Expression of natural peptide antibiotics in human skin.
Lancet
350:1750-1751[Medline].
|
| 8.
|
Ganz, T.,
M. E. Selsted, and R. I. Lehrer.
1990.
Defensins.
Eur. J. Haematol.
44:1-8[Medline].
|
| 9.
|
Ganz, T., and J. Weiss.
1997.
Antimicrobial peptides of phagocytes and epithelia.
Semin. Hematol.
34:343-354[Medline].
|
| 10.
|
Harder, J.,
J. Bartels,
E. Christophers, and J.-M. Scröder.
1997.
A peptide antibiotic from human skin.
Nature
387:861[Medline].
|
| 11.
|
Kamme, C.,
K. Lundgren, and P.-A. Mårdh.
1971.
The aetiology of acute otitis media in children.
Scand. J. Infect. Dis.
3:217-223[Medline].
|
| 12.
|
Krisanaprakornkit, S.,
A. Weinberg,
C. N. Perez, and B. A. Dale.
1998.
Expression of the peptide antibiotic human -defensin 1 in cultured gingival epithelial cells and gingival tissue.
Infect. Immun.
66:4222-4228[Abstract/Free Full Text].
|
| 13.
|
Lehrer, R. I.,
A. K. Lichtenstein, and T. Ganz.
1993.
Defensins: antimicrobial and cytotoxic peptides of mammalian cells.
Annu. Rev. Immunol.
11:105-128[Medline].
|
| 14.
|
Lim, D. J.
1968.
Tympanic membrane. I. Pars tensa.
Acta Otolaryngol.
66:181-198[Medline].
|
| 15.
|
Lim, D. J.
1968.
Tympanic membrane. II. Pars flaccida.
Acta Otolaryngol.
66:47-56.
|
| 16.
|
Liu, L.,
C. Zhao,
H. H. Q. Heng, and T. Ganz.
1997.
The human beta-defensin-1 and alpha-defensins are encoded by adjacent genes: two peptide families with differing disulfide topology share a common ancestry.
Genomics
43:316-320[Medline].
|
| 17.
|
Loennechen, T.,
U. Moens,
H. Kildalsen,
A. Andersen,
O. P. Rekvig, and A. Aarbakke.
1997.
Effects of 3-deazaadenosine on apoptosis-related gene transcripts in HL-60 cells.
Pharmacol. Toxicol.
81:199-204[Medline].
|
| 18.
|
McCray, P. B., Jr., and L. Bentley.
1997.
Human airway epithelia express a beta-defensin.
Am. J. Respir. Cell Mol. Biol.
16:343-349[Abstract].
|
| 19.
|
McGinley, K. J.,
J. J. Leyden,
R. R. Marples,
M. R. C. Path, and A. M. Kligman.
1975.
Quantitative microbiology of the scalp in non-dandruff, dandruff, and seborrhoeic dermatitis.
J. Invest. Dermatol.
64:401-405[Medline].
|
| 20.
|
Nissen-Meyer, J., and I. F. Nes.
1997.
Ribosomally synthesized antimicrobial peptides: their function, structure, biogenesis, and mechanism of action.
Arch. Microbiol.
167:67-77[Medline].
|
| 21.
|
Ostfeld, E.,
E. Rubinstein, and E. Gazit.
1977.
Effect of systemic antibiotics on the microbial flora of the external ear canal in hospitalized children.
Pediatrics
60:364-368[Abstract/Free Full Text].
|
| 22.
|
Potter, B. S.,
C. F. Burgoon, and J. E. Johnson.
1973.
Pityrosporum folliculitis.
Arch. Dermatol.
107:388-391[Medline].
|
| 23.
|
Schnapp, D.,
C. J. Reid, and A. Harris.
1998.
Localization of expression of human beta defensin-1 in the pancreas and kidney.
J. Pathol.
186:99-103[Medline].
|
| 24.
|
Singh, P. K.,
H. P. Jia,
K. Wiles,
J. Hesselberth,
L. D. Liu,
B. A. D. Conway,
E. P. Greenberg,
E. V. Valore,
M. J. Welsh,
T. Ganz,
B. F. Tack, and P. B. McCray, Jr.
1998.
Production of -defensins by human airway epithelia.
Proc. Natl. Acad. Sci. USA
95:14961-14966[Abstract/Free Full Text].
|
| 25.
|
Sipilä, P.,
A. M. M. Jokipii,
L. Jokipii, and P. Karma.
1981.
Bacteria in the middle ear and ear canal of patients with secretory otitis media and noninflamed ears.
Acta Otolaryngol.
92:123-130[Medline].
|
| 26.
|
Stenfors, L.-E.,
G. D. Blom, and S. Hellström.
1984.
The tympanic membrane.
Acta Otolaryngol.
414(Suppl.):28-30.
|
| 27.
|
Stenfors, L.-E., and S. Räisänen.
1991.
Is Pityrosporum ovale a pathogen of the external auditory meatus?
Acta Otolaryngol.
111:943-945[Medline].
|
| 28.
|
Stone, M., and R. S. Fulghum.
1984.
Bactericidal activity of wet cerumen.
Ann. Otol. Rhinol. Laryngol.
93:183-186[Medline].
|
| 29.
|
Valore, E. V.,
C. H. Park,
A. J. Quale,
K. R. Wiles,
P. B. McCray, Jr., and T. Ganz.
1998.
Human -defensin-1: an antimicrobial peptide of urogenital tissues.
J. Clin. Invest.
101:1633-1642[Medline].
|
| 30.
|
Zhao, C.,
I. Wang, and R. I. Lehrer.
1996.
Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells.
FEBS Lett.
396:319-322[Medline].
|
Infection and Immunity, September 1999, p. 4843-4846, Vol. 67, No. 9
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Weinberg, A., Quinones-Mateu, M.E., Lederman, M.M.
(2006). Role of Human {beta}-defensins in HIV Infection. Adv. Dent. Res.
19: 42-48
[Abstract]
[Full Text]